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OBJECTIVES We prospectively evaluated the mechanism of syncope in patients with positive adenosine
triphosphate (ATP) tests (defined as the induction of atrioventricular [AV] block with a
ventricular pause 6 s after an intravenous bolus of 20 mg ATP).
BACKGROUND Patients with unexplained syncope tend to have more positive ATP tests results than those
without syncope.
METHODS An implantable loop recorder (ILR) was inserted in 36 ATP-positive patients (69 10 years;
22 women; median of 6 syncopal episodes); 15 of them also had a positive response to tilt
testing.
RESULTS During the follow-up of 18  9 months, 18 patients (50%) had syncopal recurrence and 16
(44%) had an electrocardiographically documented episode: AV block (n  3: paroxysmal in
2 and permanent in 1), AV block followed by sinus arrest (n  1), sinus arrest (n  5), sinus
bradycardia 40 beats/min (n  2), normal sinus rhythm (n  2), sinus tachycardia (n  1),
rapid atrial fibrillation (n  1), and ectopic atrial tachycardia (n  1). Bradycardia was
documented in a total of 11 cases (69%), and a long ventricular pause (4 to 29 s) was present
in eight cases (50%). All three patients with ILR-documented AV block had previously had
a negative tilt test, whereas seven of eight with ILR-documented sinus bradycardia or sinus
arrest had previously had a positive tilt test.
CONCLUSIONS In patients with adenosine-sensitive syncope, the mechanism of syncope is heterogeneous,
although bradycardia is the most frequent finding. Adenosine triphosphate–induced AV
block predicts AV block as the mechanism of spontaneous syncope in only a few tilt-negative
patients. (J Am Coll Cardiol 2003;41:93–8) © 2003 by the American College of
Cardiology Foundation
Intravenous injection of adenosine triphosphate (ATP) has
recently been proposed as an investigative tool in patients
with unexplained syncope (1,2). In predisposed patients
with unexplained syncope, the cardiac action of adenosine,
which has a powerful dromotropic effect on the atrioven-
tricular (AV) node (3), causes prolonged ventricular pauses
that are due to AV block and that are suspected of being
responsible for spontaneous attacks. The action of ATP is
due to its rapid catabolism to adenosine and the subsequent
action of adenosine at purinoceptor sites. Adenosine and
ATP have similar effects in humans (3), even if some vagal
effect may be exerted by ATP but not by adenosine in the
canine heart (4). Patients with unexplained syncope are
reported to show greater susceptibility to ATP, as demon-
strated by their positive ATP tests, than those without
syncope (1,2). Also, ATP testing has been shown to
reproduce AV block (and suggest the mechanism of syn-
cope) in a few patients with fortuitous documentation of
spontaneous paroxysmal AV block, especially in those with-
out abnormalities of AV conduction or of the autonomic
nervous system (2). The logical inference is that ATP
testing can identify patients with syncope due to transient
AV block, even when electrophysiologic findings and other
conventional tests are unremarkable. However, this inter-
esting hypothesis remains to be confirmed. In the present
prospective study, we identified and followed up a consec-
utive group of patients with adenosine-sensitive syncope,
with the aim of demonstrating the causal relationship
between increased susceptibility to adenosine and syncope
due to paroxysmal AV block.
METHODS
Study protocol. Consecutive patients with adenosine-
sensitive syncope who met the inclusion criteria received an
implantable loop recorder (ILR) and were followed up to
obtain electrocardiographic (ECG) documentation of a
spontaneous syncopal relapse.
Patients were considered eligible if they were 40 years
old, had previously had three or more syncopal episodes
with an interval of 6 months between the first and last
episode, and had a clinical presentation severe enough
(because of a high number of spells or high risk) to require
treatment, if any was available. Patients were included in the
study only if a careful history, physical examination, baseline
ECG, carotid sinus massage, echocardiogram, and 24-h
ambulatory recording were not diagnostic of the etiology of
syncope. Any other test necessary for a definitive diagnosis
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of the cause of syncope was performed when clinically
indicated. In particular, an electrophysiologic study was
performed in the case of cardiac abnormalities or a history of
palpitations.
Because of the overlap between adenosine-sensitive syn-
cope and tilt-induced syncope (5,6), all patients underwent
tilt testing. The tilt-test protocol always included a 20 min
passive phase and a subsequent 15 min phase with nitro-
glycerin provocation, according to the Italian protocol (7).
Patients with positive response to both ATP and tilt testing
were included in the study.
Protocol of the ATP test. The ATP test consisted of
injecting a 20-mg bolus (3 s) of ATP dissolved in 10 ml
of saline solution into a brachial vein, followed by a 20-ml
flush of dextrose solution (1,2). During injection, patients
remained supine, and continuous ECG recordings were
made just before and 2 min after drug administration. Blood
pressure was monitored non-invasively. Interpretation of
the test result was based exclusively on the duration of the
maximum ventricular pause (maximum RR interval). A
value 6 s was defined as abnormal (2). In a previous study
(2), this value was found in 28% of patients with syncope of
unknown origin and in 5% of control subjects without
syncope.
End point. When patients were deemed eligible, an ILR
(Reveal, Medtronic) was implanted subcutaneously. The
recommended program mode was one event, 21 min before
activation and 1 min after activation. Patients were in-
structed to activate the device after every episode of syncope
or pre-syncope. The records of all episodes were retrieved,
printed, and analyzed. The primary end point of this study
was the analysis of the ECG tracing obtained during the
first syncopal episode that was correctly recorded by the
device.
Control group. As control group, 15 patients (61  13
years; 10 men) who had negative ATP and tilt tests were
evaluated. They were all consecutive patients who had
received an ILR device during the same period of recruit-
ment because of unexplained syncope; they had received the
same workup as described for the study patients. An ATP
injection had induced a pause of 2.6  0.8 s.
Statistical methods. A comparison between groups was
carried out by means of the Student t test for continuous
variables and the Fisher exact test for proportions. The time
to onset of events was analyzed by means of Kaplan-Meier
survival curves.
RESULTS
From January 1998 to December 2000, 36 patients were
included. The clinical characteristics of the patients are
shown in Table 1. Patients were seen at the outpatient clinic
every three months until the primary end point was reached
or the study ended. The mean follow-up was of 18  9
months (minimum 3 months) and was completed in De-
cember 2001. Syncope recurred in 18 patients (50%); their
actuarial estimates of recurrence were 11%, 26%, and 42% at
3, 9, and 15 months, respectively.
Among the 15 patients comprising the control group,
syncope recurred and could be documented by the ILR in
nine (60%) during a mean follow-up of 16  9 months.
Primary end point. An ILR-documented syncopal event
occurred in 16 adenosine-sensitive patients (44%) after a
median nine months (interquartile range 3 to 13) (Table 2).
Two other patients were unable to activate the device at the
time of their syncopal relapse. Atrioventricular block was
recorded in three cases (19%) (paroxysmal in two and
permanent in one), AV block followed by sinus arrest in one
case, sinus arrest in five cases (mostly preceded by progres-
sive bradycardia and/or tachycardia), progressive sinus bra-
dycardia 40 beats/min in two cases, normal sinus rhythm
in two cases, progressive sinus tachycardia in one case, rapid
atrial fibrillation in one case, and ectopic atrial tachycardia
in one case. Bradycardia was documented in 11 cases (69%),
and a long ventricular pause (4 to 29 s) was present in eight
cases (50%). The ATP test results were similar in the
patients who had syncopal recurrence and in those who did
not (maximum pause of 8.4 vs. 8.2 s, respectively) and also
in the subgroup who had recurrence due to bradycardia
(maximum pause of 8.6 s).
Three patients had AV block. Patient no. 1 was a
63-year-old woman who had had seven unexplained synco-
pal attacks over the previous 10 years; conventional inves-
Abbreviations and Acronyms
ATP  adenosine triphosphate
AV  atrioventricular
ECG electrocardiogram
ILR  implantable loop recorder
Table 1. Patient Characteristics (n  36)
Age (yrs) 69  10 (range 41–82)
Female gender 22 (61%)
History of syncope
Duration of syncope in years (median,
interquartile range)
4 (2–10)
Number of syncopal episodes (range) 6 (4–10)
Number of syncopes per last year
(median, interquartile range)
3 (2–5)
Patients with presyncopal episodes 22 (61%)
Situational or vasovagal symptoms
before episode
10 (28%)
No warnings 18 (50%)
Associated structural heart disease 10 (28%)
Hypertensive 8
Ischemic 1
Congenital 1
ATP response
AV block, maximal ventricular pause (s) 8.3  2.4
AV block, total duration (s) 16.4  8.6
Data are presented as the mean value  SD, number (%) of patients, or median value
(interquartile range).
ATP  adenosine triphosphate; AV  atrioventricular.
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tigations, including tilt testing, were negative, and no signs
of structural heart disease were detected. Adenosine triphos-
phate caused AV block of 15-s duration, with a main pause
of 8.6 s. The recorded event (Fig. 1) was sudden-onset AV
block, with a primary ventricular pause lasting 12 s and
followed by further secondary pauses. The overall episode
lasted 18 s before normal sinus rhythm suddenly resumed;
syncope was also sudden and without prodromes. Patient
no. 2 was a 54-year-old woman with a history of 15
unexplained syncopal attacks over the previous six years;
conventional investigations, including tilt testing, were neg-
ative, and there was no sign of structural heart disease. The
result of the ATP test is shown in Figure 2. The ILR-
recorded event (Fig. 3) was very similar to that induced
during the ATP test, in that there was sudden-onset AV
block with a primary ventricular pause lasting 7 s, followed
by further secondary pauses; the overall episode lasted 15 s
before normal sinus rhythm suddenly resumed. Syncope was
preceded for a few seconds by a feeling of imminent
fainting. A few months before syncope, she had had an
ILR-documented pre-syncopal episode due to 2:1 second-
degree AV block of 10 s duration. Patient no. 3 was a
78-year-old woman affected by hypertension who had a
history of four syncopal attacks over the previous three years;
conventional investigations, including tilt testing, were neg-
ative. Adenosine triphosphate caused AV block lasting 43 s,
with a main pause of 14 s. The recorded syncopal event was
sudden-onset, third-degree AV block (35 beats/min), which
persisted for a few hours (in-hospital ECG documentation).
Secondary end points. A positive response during tilt
testing was observed in 15 cases (42%): cardioinhibitory in
six, mixed in seven, and vasodepressive in two. With regard
to the baseline clinical features (Table 1), these patients
differed from the 21 with negative responses only in terms of
their higher prevalence of situational or vasovagal symptoms
before loss of consciousness (47% vs. 14%, p  0.05). Eight
patients in each of the two groups had ILR-documented
recurrence of syncope during follow-up (Table 2 and 3).
Seven (87%) of the eight patients with a positive tilt test
showed sinus bradycardia or sinus arrest. By contrast, the
three patients who had isolated AV block belonged to the
group of eight patients with negative tilt tests (37%).
Also, in the control group, as well as in the tilt-positive
group, sinus bradycardia or sinus arrest was the most
Table 2. Patients With Syncope Documented by Implantable Loop Recorder
Patient
No.
Time Since
Enrollment
(months) Description of Event
Ventricular
Pauses (s)
Total
Duration (s)
ATP Maximal
RR Interval (s)
Tilt Test
Result
1 2 Sudden-onset paroxysmal third-degree
AV block
12 18 8.6 
2 11 Sudden-onset paroxysmal third-degree
AV block
722 15 6 
3 36 Sudden-onset third-degree AV block
persisting for a few hours
None Undefined 14 
4 10 Sudden-onset third-degree AV block
with a 5 s pause followed by
progressive sinus bradycardia and
SA of 29 s and then junctional
bradycardia
529 40 6 
5 1 Progressive sinus bradycardia followed
by SA
7 160 6.6 
6 18 Progressive sinus bradycardia followed
by SA
976 60 12.4 
7 18 Progressive sinus bradycardia followed
by SA
334 30 6.2 
8 3 Sinus tachycardia followed by
progressive sinus bradycardia, SA,
and atrial fibrillation
844 90 11 
9 1 Sudden-onset SA 259 34 7 
10 2 Progressive sinus bradycardia up to
35 beats/min
 420 8 
11 29 Progressive sinus bradycardia then
junctional rhythm at 40 beats/min
 330 8.6 
12 3 Sinus rhythm, no variations  Undefined 8 
13 4 Sinus rhythm, no variations  Undefined 6.2 
14 11 Progressive sinus tachycardia at
120 beats/min
 180 8.8 
15 11 Rapid atrial fibrillation*  Undefined 10 
16 8 Sudden-onset ectopic atrial
tachycardia at 200 beats/min
 120 6 
*During a suspected epileptic attack (witnessed).
SA  sinus arrest;   positive response;   negative response; other abbreviations as in Table 1.
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frequent finding (Table 3). Overall, among the 17 patients
who had bradycardia in the three groups (Table 3), AV
block was significantly more frequent in the ATP-positive,
tilt-negative group (37% vs. 8%), whereas sinus bradycardia
and sinus arrest were more frequent in the tilt-positive and
control groups (92% vs. 12%; p  0.02).
Multiple syncopal episodes occurred in six patients (Pa-
tients no. 5, 6, 7, 8, 9, and 11; Table 2). In all patients, very
similar findings were observed during their second events,
and in one patient during his third event.
No patient suffered severe injury due to syncopal relapse,
and none died. An interview of a witness to the episode
recorded in Patient no. 15 suggested a diagnosis of an
epileptic attack. As a consequence of the results of the study,
seven patients had a permanent pacemaker implanted, one
underwent transcatheter ablation, and one received anti-
epileptic therapy. No therapy was undertaken in the other
patients.
DISCUSSION
The main conclusion of this prospective study is that in
patients with adenosine-sensitive syncope, the mechanism
of syncope is heterogeneous, although bradycardia is the
Figure 1. The figure shows the syncopal event observed in Patient no. 1. (A) Heart rate trend during the whole 21-min loop recording. The heart rate is
initially stable at 80 beats/min and then suddenly falls at the time of syncope. (B) Expanded electrocardiographic recording at the time of the syncopal
event. The onset of atrioventricular block is sudden, with no change in the PP interval; the main pause lasted 12 s.
Figure 2. The figure shows the result of the adenosine triphosphate (ATP) test performed in Patient no. 2. Continuous tracings of the electrocardiogram
and non-invasive blood pressure (BP) (Finapres method) are shown. The bolus of ATP causes abrupt third-degree atrioventricular (AV) block with long
ventricular asystoles of 5.2, 6.0, and 4.5 s. The sinus rate increases during the block. Thus, the effect of the drug is limited to the AV conduction system.
Systolic blood pressure dropped from an initial value of 140 mm Hg to values ranging between 80 and 110 mm Hg.
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most frequent finding. The causal relationship between
ATP-induced AV block and syncope due to paroxysmal AV
block is weak. Atrioventricular block induced by ATP
predicts AV block as the mechanism of spontaneous syn-
cope in only a few tilt-negative cases.
At the time of ILR-documented syncope, about half of
the patients showed long pauses, and two-thirds had severe
bradycardia. Sinus arrest or bradycardia was more frequent
in patients who had an associated positive response during
tilt testing. This finding is consistent with that observed in
a previous study in patients with tilt-positive syncope (8).
The finding of progressive sinus bradycardia frequently
followed by sinus arrest has been regarded as highly sug-
gestive of a neurally mediated mechanism. The association
between AV block and sinus arrest, as in Patient no. 4, also
suggests a neurally mediated mechanism (8). On the other
hand, AV block without sinus bradycardia or arrest occurred
in three (37%) of the eight patients with adenosine-sensitive
syncope and a negative tilt test. In a previous study (8), AV
block was shown to be a very uncommon mechanism in
patients with unexplained isolated syncope and in patients
with tilt-positive syncope. Atrioventricular block was also
uncommon in the control group in the present study.
Therefore, this finding might not be fortuitous. The feature
of sudden onset of AV block with no change in sinus rate or
with an increase in heart rate resembles that observed in
patients with bundle branch block who have an intrinsic AV
conduction disease (9) and argues against a neurally medi-
ated mechanism.
On the basis of the high percentage of ILR-documented
bradycardic episodes, one could suggest that the ATP test is
useful in predicting bradycardia in general, even if not AV
block specifically. Actually, other authors have claimed that
the ATP test is useful in identifying patients with severe
vasovagal syncope who might benefit from pacing therapy
(1,10). In the present study, the positivity of tilt testing,
rather than the positivity of the ATP test, seems better able
to predict subsequent cardio-inhibitory vasovagal syncope.
Moreover, in a large population of patients with unex-
plained, isolated syncope (8), and in the control group of the
present study, bradycardia was found as frequently as in
adenosine-sensitive patients, suggesting that bradycardia is a
frequent cause of syncope, regardless of the results of the
ATP test. The results of pacing therapy are also inconclu-
sive. Indeed, in one large, non-controlled study (1), syncope
recurred in 13% and 15% of paced patients with positive and
negative ATP test results, respectively. This suggests that
the beneficial effect of pacing is independent of the result of
the test and, rather, reflects the high prevalence of syncope
due to bradycardia, as shown previously.
Although the receptors are different, the cardiac actions
of adenosine are remarkably similar to those of the neuro-
transmitter acetylcholine (11). Both acetylcholine and aden-
osine produce the same effects and share similar receptor–
effector coupling systems. A major role of acetylcholine and
adenosine, in addition to their direct effect, is to function in
parallel to oppose the cardiac-stimulatory action of the
sympathetic neurotransmitters norepinephrine and epi-
nephrine on adenyl cyclase (cyclic adenosine monophos-
Figure 3. The figure shows the electrocardiographic recording of the syncopal event observed in the same patient as in Figure 2 (Patient no. 2). The onset
of atrioventricular block is sudden, with a long ventricular asystole of 7 s. The sinus rate increases during the spontaneous event. The increase in sinus rate
during the episode argues against the presence of a vagal reflex. The noise recorded probably reflects jerking movements of the patient during syncope.
Table 3. Mechanism of Syncope, as Detected by Implantable
Loop Recorder, in Patients and Control Subjects With
Adenosine-Sensitive Syncope (Both Tilt-Negative and
B4-Positive)
Patients with Adenosine-
Sensitive Syncope
Control
Subjects
Tilt-Negative
(n  8)
Tilt-Positive
(n  8)
Tilt-Negative
(n  9)
AV block 3 (37%) 0 1 (11%)
Sinus arrest 1 (12%) 5 (62%) 4 (44%)
Sinus bradycardia 0 2 (25%) 1 (11%)
No rhythm
variations
2 (25%) 0 2 (22%)
Tachycardia 2 (25%) 1 (12%) 1 (11%)
Data are presented as the number (%) of patients or control subjects.
AV  atrioventricular.
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phate–dependent effect) (3,11). Thus, adrenergic, cholin-
ergic, and purinergic outflows are integrated at the level of
the receptor–effector coupling system, and the final cardiac
effect results from the sum of these excitatory and inhibitory
effects. In addition to its cardiac effects, adenosine also
promotes vasodilation, decreases central and peripheral
sympathetic efferent nerve activity, and inhibits renin release
(12,13). The injection of ATP or adenosine causes hypo-
tension. The role of hypotension in the mechanism of
syncope is unclear. A consequence might be that vasovagal
syncope could be facilitated by an increased susceptibility to
adenosine, and that adenosine-sensitive syncope could be
facilitated by increased vagal outflow. Interestingly, in sup-
port of this supposed synergic effect, the mechanism of
syncope was bradycardic in seven (87%) of eight patients in
whom both the ATP and tilt test were positive.
A positive response to the ATP test has been shown to be
associated with typical clinical features (6) that were con-
sistently observed in the present study in the three patients
who had ILR-documented AV block. Typically, adenosine-
sensitive syncope first manifests itself in middle or old age
and is more common in females. Because the attacks nearly
always occur in the standing position and warning symp-
toms are frequently absent, loss of consciousness often
results in falls that cause injury. The lack of historical
findings of vasovagal or situational episodes and the absence
of triggering factors characterize this form and clearly
differentiate it from vasovagal syncope. Despite the old age
of patients, structural heart disease is usually absent or, if
present, mild and mainly due to a long history of hyperten-
sion. Adenosine-sensitive syncope is rare, accounting for
about 3% of patients referred for investigation of syncope
(6).
Study limitations. The results of the study are hampered
by the small number of patients in various groups, reflecting
the relative rarity of severe adenosine-sensitive syncope.
Thus, the results should be regarded as intermediate pend-
ing larger trials. Although the follow-up duration (18  9
months) was longer than that of similar studies with ILR, it
is likely that longer observations would be of considerable
interest.
Practical consequences. Because of its low positive pre-
dictive value, the ATP test has little value in evaluating
patients with unexplained syncope and in selecting treat-
ment. The favorable outcome we observed suggests the
strategy of postponing treatment, pacemaker therapy in
particular, until a definite diagnosis can be made by docu-
menting a spontaneous syncopal relapse. In accordance with
this approach, only nine patients (25%) underwent ILR-
guided specific therapy immediately after their first syncopal
documentation; no therapy was undertaken in the others.
Many other patients would probably have had a docu-
mented syncopal recurrence if the monitoring phase had
been prolonged. The usefulness of a very prolonged moni-
toring phase and the efficacy of therapy in preventing further
syncopal recurrences remain to be proved in prospective
therapy trials. Moreover, the benign nature of the clinical
syndrome, which is similar to that of neurally mediated
syncope, suggests that ILR implantation should be done
only when its clinical presentation is severe enough (because
of high number or high risk) to require treatment.
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